Explore our existing research publications and presentations.
Publications
At NGM, we pride ourselves on conducting world-class science and sharing our research efforts with the broader scientific and medical communities.
AACR Special Conference: Pancreatic Cancer
Initial Results of a Cohort of Advanced Pancreatic Cancer Patients in a Phase 1b Study of NGM120, a First-in-Class Anti-GDNF Family Receptor Alpha Like (GFRAL) Antibody
ESMO Congress 2022
Initial Results of a Cohort of Advanced Prostate Cancer Patients in a Phase 1a Study of NGM120, a First-in-class Anti-GDNF Family Receptor Alpha Like (GFRAL) Antibody
ESMO Virtual Congress; September 16-21, 2021
Initial results of a phase 1a/1b study of NGM120, a first-in-class anti-GDNF family receptor alpha like (GFRAL) antibody in patients with advanced solid tumors
Nature Medicine, 2020
Antibody-mediated inhibition of GDF15–GFRAL activity reverses cancer cachexia in mice
Nature, 2019
GDF15 mediates the effects of metformin on body weight and energy balance
Nature, 2017
Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15